Investigating the compatibility of biologic medicines with drug product containers
The CPI and Arecor investigate compatibility of biologic medicines with drug product containers.13 October 2015
Biologics are preparations, such as a drug, a vaccine, or an antitoxin, that are synthesized from living organisms or their products and used as a diagnostic, preventive, or therapeutic agent.
For the development and proving of biological pharmaceuticals CPI provides assets and resources to support innovations in the manufacture of biologics and with access to state of the art facilities and technical expertise. Capability and support for Biologics spans across: rapid process development tools and techniques for current and next generation biologics; formulation, fill and finish focused on the biologics market; specialist process analytical technologies; supply chain alignment with the future needs of healthcare providers; and workforce training and development. HVM Catapult Biologics expertise and equipment can help commercialise ideas and take them to market faster and with reduced risk.